Evidence map›Paper›PMID 40804392›Full record

ArticleBMC chemistry2025

A concise synthesis of pyrrolo[2,3-d]pyrimidine through I

Meng Xia, Siyuan Jiang, Lingxian Zhao, Ni Deng, Yue Yin, Zhenjie Liu, Suyue Duan, Xianfu Shen, Xuequan Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meng Xia *Key Laboratory of Natural Pharmaceutical and Chemical Biology of Yunnan Province, School of Chemistry and Resources Engineering, Honghe University, Mengzi, Yunnan, 661100, China.
Siyuan Jiang *Key Laboratory of Natural Pharmaceutical and Chemical Biology of Yunnan Province, School of Chemistry and Resources Engineering, Honghe University, Mengzi, Yunnan, 661100, China.
Lingxian ZhaoKey Laboratory of Natural Pharmaceutical and Chemical Biology of Yunnan Province, School of Chemistry and Resources Engineering, Honghe University, Mengzi, Yunnan, 661100, China.
Ni DengKey Laboratory of Natural Pharmaceutical and Chemical Biology of Yunnan Province, School of Chemistry and Resources Engineering, Honghe University, Mengzi, Yunnan, 661100, China.
Yue YinKey Laboratory of Natural Pharmaceutical and Chemical Biology of Yunnan Province, School of Chemistry and Resources Engineering, Honghe University, Mengzi, Yunnan, 661100, China.
Zhenjie LiuKey Laboratory of Natural Pharmaceutical and Chemical Biology of Yunnan Province, School of Chemistry and Resources Engineering, Honghe University, Mengzi, Yunnan, 661100, China.
Suyue DuanKey Laboratory of Natural Pharmaceutical and Chemical Biology of Yunnan Province, School of Chemistry and Resources Engineering, Honghe University, Mengzi, Yunnan, 661100, China. 550707920@qq.com.
Xianfu ShenYunnan Key Laboratory of Crystalline Porous Organic Functional Materials, College of Chemistry and Environmental Science, Qujing Normal University, Qujing, Yunnan, 655011, China. xianfu_shen@163.com.
Xuequan WangKey Laboratory of Natural Pharmaceutical and Chemical Biology of Yunnan Province, School of Chemistry and Resources Engineering, Honghe University, Mengzi, Yunnan, 661100, China. huolixuanfeng@126.com.

Funding

National Natural Science Foundation of China 21602050Natural Science Foundation of Yunnan Province 202101BA070001-053Natural Science Foundation of Yunnan Province 202205AC16000, 202301BA070001-102Yunnan Key Laboratory of Chiral Functional Substance Research and Application 202402AN360010Yunnan Key Laboratory of Crystalline Porous Organic Functional Materials 202449CE340024Yunnan Province International Joint Laboratory of Green Food (China-Vietnam) 202403AP140032
6 · The paper itself

Abstract

An attractive approach for the preparation of pyrrolo[2,3-d]pyrimidines has been developed via I

Indexed as

6-AminouracilI2/DMSOPyrrolo[2,3-d]pyrimidineSynthesis

Identifiers

PMID40804392
PMCPMC12344854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.